发明人徐明华,罗永刚,刘建华. "Method for the Synthesis of Oclacitinib Impurity 41" [P]. 中国发明专利, 专利号 CN 117834685 B, 授权公告日 2024-10-28.
发明人黄志刚,孙丽萍,唐晓军. "A Process for Preparing High-Purity Oclacitinib Impurity 41" [P]. 中国发明专利, 专利号 CN 112381731 B, 授权公告日 2015-12-11.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 奥拉替尼杂质41 in Pharmaceutical Formulations". Biomed. Chromatogr., 2017, 1608, (12), 4807-4822.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 奥拉替尼杂质41 as an Impurity". J. Nat. Prod., 2017, 1938, (4), 5068-5073.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Oclacitinib Impurity 41 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2018, 962, 5235-5255.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 奥拉替尼杂质41 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2013, 2013, (3), 6978-7007.